Pralatrexate
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 221 publications
Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.
Journal: BMJ case reports
Published: June 23, 2026
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
Journal: Antimicrobial agents and chemotherapy
Published: May 28, 2026
In silico discovery of novel small-molecule PD-L1 inhibitors through a multi-stage computational workflow integrating machine learning and molecular dynamics.
Journal: Journal of computer-aided molecular design
Published: February 04, 2026
Pembrolizumab and pralatrexate for relapsed or refractory peripheral T-cell lymphomas.
Journal: British journal of haematology
Published: December 22, 2025
Integrating functional genomics and proteomics identifies Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in T-cell lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Subcutaneous panniculitis-like T-cell lymphoma complicated by hemophagocytic syndrome with significant response to pralatrexate: A case report.
Journal: JAAD case reports
Published: November 10, 2025
Functional genomics and proteomics identify Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in diverse T-cell lymphoma models.
Journal: Molecular cancer therapeutics
Published: October 21, 2025
Case series of long-term responders to pralatrexate in peripheral T-cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 29, 2025
Inhibition Of One-Carbon Metabolism In Ewing Sarcoma Results In Profound And Prolonged Growth Suppression Associated With Purine Depletion.
Journal: bioRxiv : the preprint server for biology
Published: May 16, 2025
One-Carbon Metabolism Inhibition Depletes Purines and Results in Profound and Prolonged Ewing Sarcoma Growth Suppression.
Journal: Cancer research communications
Published: April 24, 2025
Pralatrexate effectively inhibits the replication of monkeypox virus in vitro and in vivo.
Journal: Antiviral research
Published: April 14, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.
Journal: Blood advances
Published: March 28, 2025
Last Updated: 06/30/2026